
Aviva plc, a prominent financial services company established in 1696 and based in London, United Kingdom, offers a broad spectrum of insurance, retirement, investment, and savings solutions. Its operations encompass the UK, Ireland, Canada, and other international territories. The company's diverse product portfolio features life assurance, long-term health and accident coverage, a range of savings schemes, pensions, and annuity products, in addition to managing pension funds and providing lifetime mortgages. Aviva also furnishes general insurance policies for private individuals and small to medium-sized enterprises (SMEs), addressing risks associated with motor vehicles, medical costs, property, and various liabilities like employer's and professional indemnity. Beyond its insurance provisions, Aviva delivers investment management services for institutional pension mandates and oversees numerous retail investment products. These retail options include investment funds, unit trusts, open-ended investment companies (OEICs), and individual savings accounts (ISAs), catering to a wide array of clients such as third-party financial institutions, pension funds, public sector entities, investment professionals, and private investors. Its offerings are made available through an extensive network of insurance brokers and its dedicated MyAviva digital platform. The company, which was initially named CGNU plc, officially adopted the Aviva plc name in July 2002.
Aviva plc trades as AV.L on LSE. The company is classified in Financial Services / Insurance - Diversified and reports in GBP.
The current profile places the business in Insurance - Diversified. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows £58.51B of revenue and £1.03B of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Aviva plc can be compared against peers such as Admiral Group plc, AIB Group plc, Hiscox Ltd, Just Group plc, Legal & General Group Plc, Phoenix Group Holdings plc.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of £18.18B, beta of 0.62, and return on equity of +10.7%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
AV.L currently shows total debt of £8.30B and beta of 0.62. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.aviva.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.